These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model. Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899 [TBL] [Abstract][Full Text] [Related]
3. Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD. Tohda C; Nakada R; Urano T; Okonogi A; Kuboyama T Int J Neurosci; 2011 Dec; 121(12):641-8. PubMed ID: 21770858 [TBL] [Abstract][Full Text] [Related]
4. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
5. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine. Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665 [TBL] [Abstract][Full Text] [Related]
6. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications. Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models]. Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632 [No Abstract] [Full Text] [Related]
8. Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway. Wang SY; Liu JP; Ji WW; Chen WJ; Fu Q; Feng L; Ma SP Chin J Nat Med; 2014 Dec; 12(12):920-8. PubMed ID: 25556063 [TBL] [Abstract][Full Text] [Related]
9. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease. Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656 [TBL] [Abstract][Full Text] [Related]
11. Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ 1-42 oligomer injection. Choi JG; Moon M; Kim HG; Mook-Jung I; Chung SY; Kang TH; Kim SY; Lee EH; Oh MS Neurobiol Learn Mem; 2011 Sep; 96(2):306-14. PubMed ID: 21689771 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin enhances learning and memory independent of amyloid load in mice. Li L; Cao D; Kim H; Lester R; Fukuchi K Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930 [TBL] [Abstract][Full Text] [Related]
13. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's disease. Meunier J; Villard V; Givalois L; Maurice T Eur J Pharmacol; 2013 Jan; 698(1-3):193-9. PubMed ID: 23123349 [TBL] [Abstract][Full Text] [Related]
14. Tau and Alzheimer's disease: the long road to anti-tangle therapeutics. Fillit HM; Refolo LM J Mol Neurosci; 2002 Dec; 19(3):249-50. PubMed ID: 12540049 [No Abstract] [Full Text] [Related]
15. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice. Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784 [TBL] [Abstract][Full Text] [Related]
16. [Advance in study on endogenous formaldehyde and pathogenesis of Alzheimer's disease]. Li WW; Guo H; Fan GW; Wang XM Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3017-20. PubMed ID: 23311145 [TBL] [Abstract][Full Text] [Related]
17. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Pillay NS; Kellaway LA; Kotwal GJ Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease. A new take on tau. Marx J Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561 [No Abstract] [Full Text] [Related]
19. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955 [TBL] [Abstract][Full Text] [Related]
20. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]